KGA-2727

CAS : 666842-36-0

Ref. 3D-RBB84236

Informations sur le produit

• Nom: KGA-2727
• CAS: 666842-36-0

Description

KGA-2727 is a novel, orally administered, non-peptidic, small molecule antidiabetic agent that increases glucose uptake in skeletal muscle cells by inhibiting the sodium-dependent glucose transporter type 2 (SGLT2) and the accompanying sodium-glucose cotransporter. KGA-2727 has been shown to lower blood pressure and increase insulin sensitivity in diabetic mice. Chronic treatment with KGA-2727 has been shown to increase insulin sensitivity in wild-type mice without any adverse effects. This drug also lowers blood sugar levels in patients with type 2 diabetes.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 536.6 g/mol
• Formule: C₂₆H₄₀N₄O₈
• Degré de pureté: Min. 95%